The ADC binds TROP2 (not topoisomerase I), is internalized, and releases a topoisomerase I inhibitor that causes DNA damage/replication stress to kill TROP2+ cells (with possible bystander killing). Topoisomerase I is the intracellular payload target, not the directly targeted antigen.